GRAIL, Inc.
GRAL- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001699031
In the last 90 days, GRAIL, Inc. insiders filed 0 open-market purchases and 4 sales; 375 institutions reported holding it in 13F filings for Q2 2026, worth $2.74B in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $7.49M in total
- 4
- 13F holdersQ2 2026, +15 vs. previous quarter
- 375
- 13F valueReported value at the end of Q2 2026
- $2.74B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding GRAL, Q2 2026
No superinvestor reported holding GRAL at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by GRAIL, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 23, 2026 (view filing)4:37 PM ET | Sep 21 | 2 days | Freidin AaronChief Financial Officer | SSale | −4.10K | $93.34 | −$382.7K | −1.6%249.0K after | 3 lots10b5-1 |
| Sep 23, 2026 (view filing)4:37 PM ET | Sep 21 | 2 days | Ofman Joshua J.Chief Executive Officer | SSale | −61.5K | $97.74 | −$6.01M | −14.5%362.3K after | 8 lots10b5-1 |
| Aug 31, 2026 (view filing)8:07 PM ET | Aug 27 | 4 days | Ofman Joshua J.Chief Executive Officer | SSale | −5.00K | $85.02 | −$425.1K | −1.2%397.3K after | 10b5-1 |
| Aug 31, 2026 (view filing)8:07 PM ET | Aug 27 | 4 days | Freidin AaronChief Financial Officer | SSale | −7.90K | $85.01 | −$671.6K | −3.0%253.1K after | 10b5-1 |
| Jun 5, 2026 (view filing) | Jun 4 | 1 day | Partridge Andrew JohnChief Growth Officer | SSale | −1.49K | $61.08 | −$91.1K | −0.9%163.7K after | |
| Apr 9, 2026 (view filing) | Apr 8 | 1 day | Freidin AaronChief Financial Officer | SSale | −45.8K | $49.92 | −$2.29M | −14.9%260.7K after | |
| Apr 9, 2026 (view filing) | Apr 8 | 1 day | Ragusa Robert PChief Executive Officer | SSale | −123.5K | $49.92 | −$6.17M | −19.2%518.6K after | |
| Apr 9, 2026 (view filing) | Apr 8 | 1 day | Ofman Joshua J.President | SSale | −61.7K | $49.92 | −$3.08M | −14.2%371.2K after | |
| Mar 9, 2026 (view filing) | Mar 5-9 | 4 days | Freidin AaronChief Financial Officer | SSale | −3.15K | $48.96 | −$154.1K | −1.0%306.5K after | 3 lots |
| Mar 9, 2026 (view filing) | Mar 5-9 | 4 days | Ofman Joshua J.President | SSale | −3.63K | $48.86 | −$177.2K | −0.8%432.9K after | 3 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in GRAIL, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Farallon Capital Management, L.L.C. | 4,161,584 | $284.1M | 1.66% | +907,900+27.9% | Added |
| Baker Bros. Advisors LP | 4,028,614 | $275.0M | 1.38% | 00.0% | Unchanged |
| BlackRock, Inc. | 3,577,075 | $244.2M | 0.00% | +608,539+20.5% | Added |
| Arbiter Partners Capital Management LLC | 3,102,891 | $211.8M | 38.65% | +2,068,294+199.9% | Added |
| State Street Corp | 2,385,514 | $162.9M | 0.00% | +493,621+26.1% | Added |
| Primecap Management Co | 2,180,106 | $148.8M | 0.09% | +336,334+18.2% | Added |
| Sessa Capital IM, L.P. | 2,037,518 | $139.1M | 2.41% | +318,204+18.5% | Added |
| Deep Track Capital, LP | 1,834,944 | $125.3M | 1.85% | +112,147+6.5% | Added |
| Vanguard Capital Management LLC | 1,641,117 | $112.0M | 0.00% | +114,012+7.5% | Added |
| Morgan Stanley | 1,462,163 | $99.8M | 0.01% | −170,032−10.4% | Reduced |